
Journal of Medicinal Chemistry p. 552 - 558 (1992)
Update date:2022-08-05
Topics:
Scott
Martin
DiStefano
Fedde
Kukla
Barrett
Baldy
Elgin Jr.
Kesslick
Mathiasen
Shank
Vaught
Recently, we reported on a series of arylpiperazines 4 which exhibit high affinity for the serotonin 5-HT-1A and 5-HT-1B binding sites. Although these compounds interact weakly with dopamine D-1 and D-2 receptors, they are reasonably potent in inhibiting conditioned avoidance responding (CAR) in the rat, an indication of potential antipsychotic activity. Conversion of these arylpiperazines to pyrrole Mannich bases has provided a series of compounds (10-44) which exhibit potent inhibition of CAR when given po and have strong affinity for both the D-2 and 5-HT-1A binding sites. Some of these agents also fail to produce catalepsy. The D-2 binding data and the block of CAR suggest that they are potential antipsychotic agents and the lack of cataleptogenic potential suggests some might possess less liability for producing extrapyramidal side effects and tardive dyskinesias in man.
View MoreContact:+852 83038667
Address:Room 1502, 15th Floor, SPA Centre,53-55 Lockhart Road, Wanchai, Hong Kong
Guangxi Shanyun Biochemical Science and Technology Co., Ltd
Contact:+86-0772--6828887
Address:#2 Industrial Park of Luzhai County, Liuzhou, Guangxi, China
Contact:+44 (0)2036089360-31
Address:Chanceryhouse,Chancery Lan
SuZhou Ascepion Pharmaceuticals, Inc.(expird)
Contact:0512-86881668
Address:Building C,68Xingqing Road,Suzhou,China.
Contact:86-575-86132822,86-575-86085355
Address:No.418 Dadao West Road,Qixing Street,Xinchang, Zhejiang Province, China.
Doi:10.1039/c8cc07009a
(2018)Doi:10.1039/c3ra44053b
(2013)Doi:10.1039/c2jm30943b
(2012)Doi:10.1016/j.inoche.2012.03.005
(2012)Doi:10.1002/adsc.201200020
(2012)Doi:10.1021/acs.joc.0c00519
(2020)